Welcome to MedLibrary.org. For best results, we recommend beginning with the navigation links at the top of the page, which can guide you through our collection of over 14,000 medication labels and package inserts. For additional information on other topics which are not covered by our database of medications, just enter your topic in the search box below:
Many causes of autism have been proposed, but understanding of the theory of causation of autism and the other autism spectrum disorders is incomplete. It was once thought that heritability contributes about 90% of the risk of a child developing autism, but environmental factors have been underestimated, and genetics overestimated, for their roles in autism-spectrum disorders. The heritability of autism is complex and it is typically unclear which genes are responsible. In rare cases, autism is strongly associated with agents that cause birth defects. Many other causes have been proposed, such as childhood immunizations, but numerous clinical studies have shown no scientific evidence supporting any link between vaccinations and autism.
Autism involves abnormalities of brain development and behavior which become apparent before a child is three years old and have a steady course with no remission. It is characterized by impairments in social interaction and communication, as well as restricted interests and stereotyped behavior, and the characterization is independent of any underlying neurological defects. It is part of a larger family called autism spectrum disorders (ASD) or pervasive developmental disorders (PDD), which include closely related disorders such as Asperger syndrome and PDD-NOS. This article uses autism to denote the classical autism and ASD to denote the wider family.
Autism's theory of causation is still incomplete. It has long been presumed that there is a common cause at the genetic, cognitive, and neural levels for autism's characteristic triad of symptoms. However, there is increasing suspicion among researchers that autism does not have a single cause, but is instead a complex disorder with a set of core aspects that have distinct causes. In other words, completely different underlying brain dysfunctions have been hypothesized to result in the common symptoms of autism, just as completely different brain problems result in mental retardation. The term "the autisms" or "the ASDs" captures the wide range of disease processes at work. Although these distinct causes have been hypothesized to often co-occur, it has also been suggested that the correlation between the causes has been exaggerated. The number of people known to have autism has increased dramatically since the 1980s, at least partly due to changes in diagnostic practice. It is unknown whether prevalence has increased as well. By 2008, the CDC's estimate for ASD prevalence was stated at 11.3 per 1000 (1 in 88) children.
The consensus among mainstream autism researchers is that genetic factors predominate. Environmental factors that have been claimed to contribute to autism or exacerbate its symptoms, or may be important to consider in future research, include certain foods, infectious disease, heavy metals, solvents, diesel exhaust, PCBs, phthalates and phenols used in plastic products, pesticides, brominated flame retardants, alcohol, smoking, illicit drugs, and vaccines. Among these factors, vaccines have attracted much attention, as parents may first become aware of autistic symptoms in their child around the time of a routine vaccination, and parental concern about vaccines has led to a decreasing uptake of childhood immunizations and an increasing likelihood of measles outbreaks. However, there is overwhelming scientific evidence showing no causal association between the measles-mumps-rubella vaccine and autism, and there is no scientific evidence that the vaccine preservative thiomersal helps cause autism.
Genetic factors may be the most significant cause for autism spectrum disorders. Early studies of twins had estimated heritability to be over 90%, meaning that genetics explains over 90% of whether a child will develop autism. However, this may be an overestimate, as new twin data and models with structural genetic variation are needed. Many of the non-autistic co-twins had learning or social disabilities. For adult siblings the risk for having one or more features of the broader autism phenotype might be as high as 30%.
The genetics of autism are complex. Linkage analysis has been inconclusive; many association analyses have had inadequate power. More than one gene may be implicated, different genes may be involved in different individuals, and the genes may interact with each other or with environmental factors. Several candidate genes have been located, but the mutations that increase autism risk have not been identified for most candidate genes. A substantial fraction of autism may be highly heritable but not inherited because the mutation that causes the autism is not present in the parental genome. One hypothesis is that autism is in some sense diametrically opposite to schizophrenia, and that autism involves increased effects via genomic imprinting of paternally expressed genes that regulate overgrowth in the brain, whereas schizophrenia involves maternally expressed genes and undergrowth.
Though autism's genetic factors explain most of the risk of developing autism, they do not explain all of it. A common hypothesis is that autism is caused by the interaction of a genetic predisposition and an early environmental insult. Several theories based on environmental factors have been proposed to address the remaining risk. Some of these theories focus on prenatal environmental factors, such as agents that cause birth defects, and others focus on the environment after birth, such as children's diets.
Risk factors for autism include parental characteristics such as advanced maternal age and advanced paternal age. The risk is greater for advanced paternal age. One hypothesis is that this is caused by older sperm that have greater mutation burden, and another is that men who carry more genetic liability have some features of autism and therefore marry and have children later. These two hypotheses are not mutually exclusive. In the largest study of this kind as of 2012, a whole genome sequencing of 78 families in Iceland showed that the number of mutations in children increased with the age of the father. Not only the fathers passed on nearly four times as many new mutations as the mothers, the number of new mutations being passed on rose exponentially with paternal age. Increased mutations will increase the risk of the children developing autism, schizophrenia and other diseases often linked to destructive mutations. 
The risk of autism is associated with several prenatal risk factors, including advanced age in either parent, diabetes, bleeding, and use of psychiatric drugs in the mother during pregnancy. Autism has been linked to birth defect agents acting during the first eight weeks from conception, though these cases are rare.
A child's risk of developing autism is associated with the age of his or her mother and father at birth. The biological reasons for this are unknown: possible explanations include increased risk of pregnancy complications; maternal autoimmunity; increased risk of chromosomal abnormalities or unstable trinucleotide repeats in the egg; and imprinted genes, spontaneous mutations, and confounding sociocultural factors in the sperm. Since ages of the father and mother are correlated, it is possible that only the mother's age, or only the father's age, or both, contribute to the risk.
Prenatal viral infection has been called the principal non-genetic cause of autism. Prenatal exposure to rubella or cytomegalovirus activates the mother's immune response and greatly increases the risk for autism. Congenital rubella syndrome is the most convincing environmental cause. Infection-associated immunological events in early pregnancy may affect neural development more than infections in late pregnancy, not only for autism, but also for other psychiatric disorders of presumed neurodevelopmental origin, notably schizophrenia.
Teratogens are environmental agents that cause birth defects. Some agents that are theorized to cause other birth defects have also been suggested as potential autism risk factors, although there is little to no scientific evidence to back such claims. These include exposure of the embryo to thalidomide, valproic acid, or misoprostol. These cases are rare. Questions have also been raised whether ethanol (grain alcohol) increases autism risk, as part of fetal alcohol syndrome or alcohol-related birth defects, but evidence is insufficient to determine whether autism risk is actually elevated with ethanol. All known teratogens appear to act during the first eight weeks from conception, and though this does not exclude the possibility that autism can be initiated or affected later, it is strong evidence that autism arises very early in development.
Other maternal conditions
Diabetes in the mother during pregnancy is a significant risk factor for autism; a 2009 meta-analysis found that gestational diabetes was associated with a twofold increased risk. Although diabetes causes metabolic and hormonal abnormalities and oxidative stress, no biological mechanism is known for the association between gestational diabetes and autism risk. A case control study  in April 2012 found that metabolic conditions (obesity, hypertension or diabetes) could be more frequent among mothers of ASD children than mothers of typical development children odds ratio: 1.61 significant. Obesity alone was significant. However, hypertension and diabetes were more frequent but this was not significant.
Thyroid problems that lead to thyroxine deficiency in the mother in weeks 8–12 of pregnancy have been postulated to produce changes in the fetal brain leading to autism. Thyroxine deficiencies can be caused by inadequate iodine in the diet, and by environmental agents that interfere with iodine uptake or act against thyroid hormones. Possible environmental agents include flavonoids in food, tobacco smoke, and most herbicides. This hypothesis has not been tested. A related untested hypothesis is that exposure to pesticides could combine with suboptimal iodine nutrition in a pregnant mother and lead to autism in the child.
Other in utero
Prenatal stress, consisting of exposure to life events or environmental factors that distress an expectant mother, has been hypothesized to contribute to autism, possibly as part of a gene-environment interaction. Autism has been reported to be associated with prenatal stress both with retrospective studies that examined stressors such as job loss and family discord, and with natural experiments involving prenatal exposure to storms; animal studies have reported that prenatal stress can disrupt brain development and produce behaviors resembling symptoms of autism.
The fetal testosterone theory hypothesizes that higher levels of testosterone in the amniotic fluid of mothers pushes brain development towards improved ability to see patterns and analyze complex systems while diminishing communication and empathy, emphasizing "male" traits over "female", or in E-S theory terminology, emphasizing "systemizing" over "empathizing". One project has published several reports suggesting that high levels of fetal testosterone could produce behaviors relevant to those seen in autism. The theory and findings are controversial and many studies contradict the idea that baby boys and girls respond differently to people and objects.
A 2006 study found that sustained exposure of mouse embryos to ultrasound waves caused a small but statistically significant number of neurons to fail to acquire their proper position during neuronal migration. It is highly unlikely that this result speaks directly to risks of fetal ultrasound as practiced in competent and responsible medical centers. There is no scientific evidence of an association between prenatal ultrasound exposure and autism, but there are very little data on human fetal exposure during diagnostic ultrasound, and the lack of recent epidemiological research and human data in the field has been called "appalling".
Autism is associated with some perinatal and obstetric conditions. A 2007 review of risk factors found associated obstetric conditions that included low birth weight and gestation duration, and hypoxia during childbirth. This association does not demonstrate a causal relationship. As a result, an underlying cause could explain both autism and these associated conditions. A 2007 study of premature infants found that those who survived cerebellar hemorrhagic injury (bleeding in the brain that injures the cerebellum) were significantly more likely to show symptoms of autism than controls without the injury.
A wide variety of postnatal contributors to autism have been proposed, including gastrointestinal or immune system abnormalities, allergies, and exposure of children to drugs, vaccines, infection, certain foods, or heavy metals. The evidence for these risk factors is anecdotal and has not been confirmed by reliable studies. The subject remains controversial and extensive further searches for environmental factors are underway.
In 1979, Jaak Panksepp proposed a connection between autism and opiates, noting that injections of minute quantities of opiates in young laboratory animals induce symptoms similar to those observed among autistic children. Opiate Theory hypothesizes that autism is caused by a digestive disorder present from birth which causes gluten (present in wheat-derived foods) and casein (present in dairy products) to be converted to the opioid peptides gliadorphin (aka gluteomorphin), and casomorphin.
According to the theory, exposure to these opiate compounds in young children interferes with normal neurological development by dulling sensory input. Lacking sufficient sensory input, the developing brain attempts to artificially generate the auditory, vestibular, visual, and tactile input on its own. This attempt at generating input manifests itself as behaviors common to autism, such as grunting or screaming (auditory), spinning or rocking back and forth (vestibular), preoccupation with spinning objects or waving of the fingers in front of the eyes (visual), and hand flapping or self-injury (tactile).
The theory further states that removing opiate precursors from a child's diet may allow time for these behaviors to cease, and neurological development in very young children to resume normally. The possibility of a relationship between autism and the consumption of gluten and casein was first articulated by Kalle Reichelt in 1991. The scientific evidence is not yet adequate to make treatment recommendations regarding diets, such as the GFCF diet, which exclude these substances.
This theory hypothesizes that autism is associated with mercury poisoning, based on perceived similarity of symptoms and reports of mercury or its biomarkers in some autistic children. This view has gained little traction in the scientific community as the typical symptoms of mercury toxicity are significantly different than symptoms seen in autism. The principal source of human exposure to organic mercury is via fish consumption and for inorganic mercury is dental amalgams. Other forms of exposure, such as in cosmetics and vaccines, also occur. The evidence so far is indirect for the association between autism and mercury exposure after birth, as no direct test has been reported, and there is no evidence of an association between autism and postnatal exposure to any neurotoxicant. A meta-analysis published in 2007 concluded that there was no link between mercury and autism.
The scientific consensus is that there is no evidence of a causal relationship between vaccinations and autism. Despite this, many parents believe that vaccinations cause autism and therefore delay or avoid immunizing their children under the "vaccine overload" hypothesis that giving many vaccines at once may overwhelm a child's immune system and lead to autism. even though this hypothesis has no scientific evidence and is biologically implausible. A study published in the Journal of Pediatrics on April 2013 found no correlation between autism and the antigen number in the vaccines the children were administered up to the age of two. The 1008 children in this study, a quarter of them were diagnosed with autism were born between 1994 and 1999, when the routine vaccine schedule could contain more than 3000 antigens (in a single shot of DTP vaccine). The vaccine schedule in 2012 contains several more vaccines but the number of antigens the child is exposed to by the age of two is 315. This study disproves the ‘vaccine overload’ theory that the increased prevalence of autism is caused by the increase in the number of childhood vaccines. As diseases like measles can cause severe disabilities and death, the risk of a child's death or disability due to not vaccinating a child is significantly larger than any minuscule risks due to vaccinating.
Perhaps the best-known hypothesis involving mercury and autism involves the use of the mercury-based compound thiomersal, a preservative that has been phased out from most childhood vaccinations in developed countries such as the USA. Parents may first become aware of autistic symptoms in their child around the time of a routine vaccination. There is no scientific evidence for a causal connection between thiomersal and autism, but parental concern about the thiomersal controversy has led to decreasing rates of childhood immunizations and increasing likelihood of disease outbreaks. Because of public concerns, thiomersal content was completely removed or dramatically reduced from childhood vaccines that contained it in the 1990s; despite this, autism rates continued to climb well into the late 2000s.
A causal link between thimerosal and autism has been rejected by international scientific and medical professional bodies including the American Medical Association, the American Academy of Pediatrics, the American College of Medical Toxicology, the Canadian Paediatric Society, the U.S. National Academy of Sciences, the Food and Drug Administration, Centers for Disease Control and Prevention, the World Health Organization, the Public Health Agency of Canada, and the European Medicines Agency.
The MMR vaccine theory of autism is one of the most extensively debated theories regarding the origins of autism. Andrew Wakefield et al. reported a study of 12 children who had autism and bowel symptoms, in some cases reportedly with onset after MMR. Although the paper, which was later retracted by the journal, concluded "We did not prove an association between measles, mumps, and rubella vaccine and the syndrome described," Wakefield nevertheless suggested during a 1998 press conference that giving children the vaccines in three separate doses would be safer than a single dose. This suggestion has been heavily criticized, both on scientific grounds and for triggering a decline in vaccination rates. Using separate, single vaccines in place of MMR is widely believed to put children at increased risk since the combined vaccine reduces the risk of them catching the diseases while they are waiting for full immunization cover. Numerous peer-reviewed studies have also since failed to show any association between MMR vaccine and autism.
In 2004, the interpretation of a causal link between MMR vaccine and autism was formally retracted by ten of Wakefield's twelve co-authors. The retraction followed an investigation by The Sunday Times, which stated that Wakefield "acted dishonestly and irresponsibly". The Centers for Disease Control and Prevention, the Institute of Medicine of the National Academy of Sciences, and the U.K. National Health Service have all concluded that there is no evidence of a link between the MMR vaccine and autism.
In July 2007 Andrew Wakefield and coauthors John Walker-Smith and Simon Murch faced charges of serious professional misconduct at the General Medical Council. It is alleged that the trio acted unethically in preparing the research into safety of the MMR vaccine. Wakefield denies the charges. In February 2009 The Sunday Times reported that Wakefield had manipulated patient data and misreported results in his 1998 paper, creating the appearance of a link with autism.
In February 2010, The Lancet, which published Wakefield's study, fully retracted it after an independent auditor found the study to be flawed. In January 2011, an investigation published in the journal BMJ described the Wakefield study as the result of deliberate fraud and manipulation of data.
This theory hypothesizes that autoantibodies that target the brain or elements of brain metabolism may cause or exacerbate autism. It is related to the maternal infection theory, except that it postulates that the effect is caused by the individual's own antibodies, possibly due to an environmental trigger after birth. It is also related to several other hypothesized causes; for example, viral infection has been hypothesized to cause autism via an autoimmune mechanism.
Interactions between the immune system and the nervous system begin early during embryogenesis, and successful neurodevelopment depends on a balanced immune response. It is possible that aberrant immune activity during critical periods of neurodevelopment is part of the mechanism of some forms of ASD. A small percentage of autism cases are associated with infection, usually before birth. Results from immune studies have been contradictory. Some abnormalities have been found in specific subgroups, and some of these have been replicated. It is not known whether these abnormalities are relevant to the pathology of autism, for example, by infection or autoimmunity, or whether they are secondary to the disease processes. As autoantibodies are found in diseases other than ASD, and are not always present in ASD, the relationship between immune disturbances and autism remains unclear and controversial.
In addition, researchers are investigating the theory that certain maternal autoantibodies circulating to the fetus could contribute to the development of autism spectrum disorders.
Many studies have presented evidence for and against association of autism with viral infection after birth. Laboratory rats infected with Borna disease virus show some symptoms similar to those of autism but blood studies of autistic children show no evidence of infection by this virus. Members of the herpes virus family may have a role in autism, but the evidence so far is anecdotal. Viruses have long been suspected as triggers for immune-mediated diseases such as multiple sclerosis but showing a direct role for viral causation is difficult in those diseases, and mechanisms whereby viral infections could lead to autism are speculative.
The hygiene hypothesis is to some extent the inverse of the viral infection hypothesis: it states that a lack of early childhood exposure to microbes or parasites contributes to autism. This hypothesis relies on some similarities between autism and asthma and other autoimmune disorders which are already hypothesized to be affected by hygiene: for example, autism and asthma affect more boys than girls, affect more urban than rural children, and are associated with increased neonatal head circumference. This hypothesis has not been tested scientifically.
This theory hypothesizes that toxicity and oxidative stress may cause autism in some cases. Evidence includes genetic effects on metabolic pathways, reduced antioxidant capacity, enzyme changes, and enhanced biomarkers for oxidative stress; however, the overall evidence is weaker than it is for involvement oxidative stress with disorders such as schizophrenia. One theory is that stress damages Purkinje cells in the cerebellum after birth, and it is possible that glutathione is involved.
This theory hypothesizes that an early developmental failure involving the amygdala cascades on the development of cortical areas that mediate social perception in the visual domain. The fusiform face area of the ventral stream is implicated. The idea is that it is involved in social knowledge and social cognition, and that the deficits in this network are instrumental in causing autism.
Locus coeruleus–noradrenergic system
This theory hypothesizes that autistic behaviors depend at least in part on a developmental dysregulation that results in impaired function of the locus coeruleus–noradrenergic (LC-NA) system. The LC-NA system is heavily involved in arousal and attention; for example, it is related to the brain's acquisition and use of environmental cues.
Lack of vitamin D
There is some very limited support based on available research for the hypothesis that vitamin D deficiency as having a role in leading to autism. Authors of a review urged more research in this area.
Lead poisoning has been suggested as a possible risk factor for autism, as the lead blood levels of autistic children has been reported to be significantly higher than typical. The atypical eating behaviors of autistic children, along with habitual mouthing and pica, make it hard to determine whether increased lead levels are a cause or a consequence of autism.
Leaky gut syndrome
Parents have reported gastrointestinal (GI) disturbances in autistic children, and several studies have investigated possible associations between autism and the gut. The now-retracted Wakefield et al. paper also suggested that some bowel disorders may allow antigens to pass from food into the bloodstream and then to contribute to brain dysfunction. Although Wakefield later proposed the term autistic enterocolitis, his studies' methodology has been criticized, their results have not been replicated by other groups, and Wakefield has been accused of manipulating patient data and misreporting results.
There is no research evidence that autistic children are more likely to have GI symptoms than typical children. In particular, design flaws in studies of elimination diets mean that the data are inadequate to guide treatment recommendations. A 2008 study found that children with autism had no more peptides in their urine than typical children, casting doubt on the proposed mechanism underlying the leaky-gut theory.
In another example, a 1998 study of three children with ASD treated with secretin infusion reported improved GI function and dramatic improvement in behavior, which suggested an association between GI and brain function in autistic children, although the low number of patients is statistically insignificant. After this study, many parents sought secretin treatment and a black market for the hormone developed quickly. However, later studies found secretin ineffective in treating autism.
A 2008 preliminary case-control study based on a parent survey presented evidence that paracetamol (acetaminophen, Tylenol) following MMR vaccine is apparently associated with development of autism in children aged 1–5 years. The effect has not been independently confirmed. More evidence for the hypothesis is that in the U.S. paracetamol began to replace aspirin for infants and young children in the 1980s, about the same time that the number of known autism cases began to rise. However, a similar rise in autism occurred in France, where children continued to receive aspirin.
Bruno Bettelheim believed that autism was linked to early childhood trauma, and his work was highly influential for decades both in the medical and popular spheres. Parents, especially mothers, of individuals with autism were blamed for having caused their child's condition through the withholding of affection. Leo Kanner, who first described autism, suggested that parental coldness might contribute to autism. Although Kanner eventually renounced the theory, Bettelheim put an almost exclusive emphasis on it in both his medical and his popular books. Treatments based on these theories failed to help children with autism, and after Bettelheim's death, it came out that his reported rates of cure (around 85%) were found to be fraudulent.
Other psychogenic theories
Psychogenic theories in general have become increasingly unpopular, particularly since twin studies have shown that autism is highly heritable. Nevertheless, some case reports have found that deep institutional privation can result in "quasi-autistic" features without the neuroanatomical differences. Other case reports have suggested that children predisposed genetically to autism can develop "autistic devices" in response to traumatic events such as the birth of a sibling.
Like ADHD, which has a similar social construct theory, a spectral disorder such as autism may be understood as a cultural or social construct. The theory says that the boundary between normal and abnormal is subjective and arbitrary, so autism does not exist as an objective entity, but only as a social construct. It further argues that autistic individuals themselves have a way of being that is partly socially constructed.
Asperger syndrome and high-functioning autism are particular targets of the theory that social factors determine what it means to be autistic. The theory hypothesizes that individuals with these diagnoses inhabit the identities that have been ascribed to them, and promote their sense of well-being by resisting or appropriating autistic ascriptions.
The "extreme male brain theory" of autism views autism as an extreme version of male-female differences regarding "systemizing" and empathizing abilities. Evolutionary psychological explanations for these sex differences include that moderate systemizing would be helpful for male dominated activities such as hunting while empathizing would be similarly helpful in female dominated activities such as caring for children. However, extreme systemizing in combination with low empathizing would lead to autism. One explanation for the increased prevalence of autism may be increased assortative mating between high systemizers.
The "imprinted brain theory" is a somewhat similar but not identical theory that considers autism and psychosis to be contrasting disorders on a number of different variables. This is argued to caused by an unbalanced genomic imprinting favoring paternal genes in the case of autism and maternal genes in the case of psychosis.
- Trottier G, Srivastava L, Walker CD. Etiology of infantile autism: a review of recent advances in genetic and neurobiological research. J Psychiatry Neurosci. 1999;24(2):103–115. PMID 10212552.
- Hallmayer, J.; Cleveland, S., Torres, A., Phillips, J., Cohen, B., Torigoe, T., Miller, J., Fedele, A., Collins, J., Smith, K., Lotspeich, L., Croen, L. A., Ozonoff, S., Lajonchere, C., Grether, J. K., Risch, N. (2011). "Genetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism". Archives of General Psychiatry 68 (11): 1095–1102. doi:10.1001/archgenpsychiatry.2011.76.
- Freitag CM. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry. 2007;12(1):2–22. doi:10.1038/sj.mp.4001896. PMID 17033636.
- Arndt TL, Stodgell CJ, Rodier PM. The teratology of autism. Int J Dev Neurosci. 2005;23(2–3):189–99. doi:10.1016/j.ijdevneu.2004.11.001. PMID 15749245.
- Rutter M. Incidence of autism spectrum disorders: changes over time and their meaning. Acta Paediatr. 2005;94(1):2–15. doi:10.1111/j.1651-2227.2005.tb01779.x. PMID 15858952.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th, text revision (DSM-IV-TR) ed. 2000 [cited 2009-02-17]. ISBN 0-89042-025-4 [Amazon-US | Amazon-UK]. Diagnostic criteria for 299.00 Autistic Disorder.
- World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 10th (ICD-10) ed. 2006 [cited 2007-06-25]. F84. Pervasive developmental disorders.
- Happé F, Ronald A. The 'fractionable autism triad': a review of evidence from behavioural, genetic, cognitive and neural research. Neuropsychol Rev. 2008;18(4):287–304. doi:10.1007/s11065-008-9076-8. PMID 18956240.
- Happé F, Ronald A, Plomin R. Time to give up on a single explanation for autism. Nat Neurosci. 2006;9(10):1218–20. doi:10.1038/nn1770. PMID 17001340.
- Geschwind DH. Advances in autism. Annu Rev Med. 2009;60:367–80. doi:10.1146/annurev.med.60.053107.121225. PMID 19630577.
- Mandy WP, Skuse DH. What is the association between the social-communication element of autism and repetitive interests, behaviours and activities? J Child Psychol Psychiatry. 2008;49(8):795–808. doi:10.1111/j.1469-7610.2008.01911.x. PMID 18564070.
- Newschaffer CJ, Croen LA, Daniels J et al. The epidemiology of autism spectrum disorders [PDF]. Annu Rev Public Health. 2007 [cited 2009-10-10];28:235–58. doi:10.1146/annurev.publhealth.28.021406.144007. PMID 17367287.
- Christison GW, Ivany K. Elimination diets in autism spectrum disorders: any wheat amidst the chaff? J Dev Behav Pediatr. 2006;27(2 Suppl 2):S162–71. doi:10.1097/00004703-200604002-00015. PMID 16685183.
- Doja A, Roberts W. Immunizations and autism: a review of the literature. Can J Neurol Sci. 2006;33(4):341–6. PMID 17168158.
- Taylor B. Vaccines and the changing epidemiology of autism. Child Care Health Dev. 2006;32(5):511–9. doi:10.1111/j.1365-2214.2006.00655.x. PMID 16919130.
- Sykes NH, Lamb JA. Autism: the quest for the genes. Expert Rev Mol Med. 2007;9(24):1–15. doi:10.1017/S1462399407000452. PMID 17764594.
- Folstein SE, Rosen-Sheidley B. Genetics of autism: complex aetiology for a heterogeneous disorder. Nat Rev Genet. 2001;2(12):943–55. doi:10.1038/35103559. PMID 11733747.
- Persico AM, Bourgeron T. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci. 2006;29(7):349–58. doi:10.1016/j.tins.2006.05.010. PMID 16808981.
- Beaudet AL. Autism: highly heritable but not inherited. Nat Med. 2007;13(5):534–6. doi:10.1038/nm0507-534. PMID 17479094.
- Awadalla, P.; Gauthier, J.; Myers, R. A.; Casals, F.; Hamdan, F. F.; Griffing, A. R.; Côté, M.; Henrion, E. et al. (2010). "Direct Measure of the De Novo Mutation Rate in Autism and Schizophrenia Cohorts". The American Journal of Human Genetics 87: 316. doi:10.1016/j.ajhg.2010.07.019.
- Crespi B, Badcock C. Psychosis and autism as diametrical disorders of the social brain. Behav Brain Sci. 2008;31(3):241–61. doi:10.1017/S0140525X08004214. PMID 18578904.
- Gardener H, Spiegelman D, Buka SL. Prenatal risk factors for autism: comprehensive meta-analysis. Br J Psychiatry. 2009;195(1):7–14. doi:10.1192/bjp.bp.108.051672. PMID 19567888.
- Callaway, Ewen (2012). "Fathers bequeath more mutations as they age". Nature (Nature) 488 (7412): 439. doi:10.1038/488439a.
- Stefansson, Kari; Kong, Augustine; Frigge, Michael; Masson, Gisli; Besenbacher, Soren; Sulem, Patrick; Magnusson, Gisli; Gudjonsson, Sigurjon et al. (2012). "Rate of de novo mutations and the importance of father’s age to disease risk". Nature (Nature) 488 (7412): 471–475. doi:10.1038/nature11396.
- Szpir M. Tracing the origins of autism: a spectrum of new studies. Environ Health Perspect. 2006;114(7):A412–8. doi:10.1289/ehp.114-a412. PMID 16835042. PMC 1513312.
- Durkin MS, Maenner MJ, Newschaffer CJ et al.. Advanced parental age and the risk of autism spectrum disorder. Am J Epidemiol. 2008;168(11):1268–76. doi:10.1093/aje/kwn250. PMID 18945690. PMC 2638544.
- Shelton JF, Tancredi DJ, Hertz-Picciotto I. Independent and dependent contributions of advanced maternal and paternal ages to autism risk. Autism Res. 2010. doi:10.1002/aur.116. PMID 20143326.
- Patterson PH. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res. 2008;204(2):313–21. doi:10.1016/j.bbr.2008.12.016. PMID 19136031.
- Mendelsohn NJ, Schaefer GB. Genetic evaluation of autism. Semin Pediatr Neurol. 2008;15(1):27–31. doi:10.1016/j.spen.2008.01.005. PMID 18342258.
- Meyer U, Yee BK, Feldon J. The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?. Neuroscientist. 2007;13(3):241–56. doi:10.1177/1073858406296401. PMID 17519367.
- Fombonne E. Is exposure to alcohol during pregnancy a risk factor for autism. J Autism Dev Disord. 2002;32(3):243. doi:10.1023/A:1015466100838. PMID 12108626.
- Krakowiak, Paula (April 2012). "Maternal Metabolic Conditions and Risk for Autism and Other Neurodevelopmental Disorders". Pediatrics.
- Román GC. Autism: transient in utero hypothyroxinemia related to maternal flavonoid ingestion during pregnancy and to other environmental antithyroid agents. J Neurol Sci. 2007;262(1–2):15–26. doi:10.1016/j.jns.2007.06.023. PMID 17651757.
- Sullivan KM. The interaction of agricultural pesticides and marginal iodine nutrition status as a cause of autism spectrum disorders. Environ Health Perspect. 2008;116(4):A155. doi:10.1289/ehp.11010. PMID 18414608. PMC 2291008.
- Muskiet FA, Kemperman RF. Folate and long-chain polyunsaturated fatty acids in psychiatric disease. J Nutr Biochem. 2006;17(11):717–27. doi:10.1016/j.jnutbio.2006.02.001. PMID 16650750.
- Kinney DK, Munir KM, Crowley DJ, Miller AM. Prenatal stress and risk for autism. Neurosci Biobehav Rev. 2008;32(8):1519–32. doi:10.1016/j.neubiorev.2008.06.004. PMID 18598714.
- Fetal testosterone and autistic traits:
- Auyeung B, Baron-Cohen S. A role for fetal testosterone in human sex differences. In: Zimmerman AW. Autism: Current Theories and Evidence. Humana; 2009. doi:10.1007/978-1-60327-489-0_8. ISBN 978-1-60327-488-3 [Amazon-US | Amazon-UK]. p. 185–208.
- Manson JE. Prenatal exposure to sex steroid hormones and behavioral/cognitive outcomes. Metabolism. 2008;57(Suppl 2):S16–21. doi:10.1016/j.metabol.2008.07.010. PMID 18803959.
- Spelke ES. Sex differences in intrinsic aptitude for mathematics and science?: a critical review [PDF]. Am Psychol. 2005 [cited 2009-04-06];60(9):950–8. doi:10.1037/0003-066X.60.9.950. PMID 16366817.
- Ang ES Jr, Gluncic V, Duque A, Schafer ME, Rakic P. Prenatal exposure to ultrasound waves impacts neuronal migration in mice. Proc Natl Acad Sci USA. 2006;103(34):12903–10. doi:10.1073/pnas.0605294103. PMID 16901978. PMC 1538990.
- Caviness VS, Grant PE. Our unborn children at risk? Proc Natl Acad Sci USA. 2006;103(34):12661–2. doi:10.1073/pnas.0605505103. PMID 16912111. PMC 1568904.
- Abramowicz JS. Prenatal exposure to ultrasound waves: is there a risk?. Ultrasound Obstet Gynecol. 2007;29(4):363–7. doi:10.1002/uog.3983. PMID 17352453.
- Kolevzon A, Gross R, Reichenberg A. Prenatal and perinatal risk factors for autism. Arch Pediatr Adolesc Med. 2007;161(4):326–33. doi:10.1001/archpedi.161.4.326. PMID 17404128.
- Limperopoulos C, Bassan H, Gauvreau K et al. Does cerebellar injury in premature infants contribute to the high prevalence of long-term cognitive, learning, and behavioral disability in survivors? Pediatrics. 2007;120(3):584–93. doi:10.1542/peds.2007-1041. PMID 17766532.
- Panksepp, J. (1979) A neurochemical theory of autism. Trends in Neurosciences, 2, 174-177
- Christison GW, Ivany K (2006). "Elimination diets in autism spectrum disorders: any wheat amidst the chaff?". J Dev Behav Pediatr 27 (2 Suppl 2): S162–71. doi:10.1097/00004703-200604002-00015. PMID 16685183.
- Reichelt KL, Knivsberg A-M, Lind G, Nødland M. Probable etiology and possible treatment of childhood autism. Brain Dysfunct 1991; 4: 308-19
- Shattock P, Whiteley P. (2002) "Biochemical aspects in autism spectrum disorders: updating the opioid-excess theory and presenting new opportunities for biomedical intervention" "Autism Research Unit, University of Sunderland, UK.
- Austin D. An epidemiological analysis of the 'autism as mercury poisoning' hypothesis. Int J Risk Saf Med. 2008;20(3):135–42. doi:10.3233/JRS-2008-0436.
- Nelson KB, Bauman ML (2003). "Thimerosal and autism?". Pediatrics 111 (3): 674–9. doi:10.1542/peds.111.3.674. PMID 12612255.
- Davidson PW, Myers GJ, Weiss B. Mercury exposure and child development outcomes. Pediatrics. 2004;113(4 Suppl):1023–9. doi:10.1542/peds.113.4.S1.1023. PMID 15060195.
- Ng DK, Chan CH, Soo MT, Lee RS. Low-level chronic mercury exposure in children and adolescents: meta-analysis. Pediatr Int. 2007;49(1):80–7. doi:10.1111/j.1442-200X.2007.02303.x. PMID 17250511.
- Gross L. A broken trust: lessons from the vaccine–autism wars. PLoS Biol. 2009;7(5):e1000114. doi:10.1371/journal.pbio.1000114. PMID 19478850. PMC 2682483.
- Hilton S, Petticrew M, Hunt K. 'Combined vaccines are like a sudden onslaught to the body's immune system': parental concerns about vaccine 'overload' and 'immune-vulnerability'. Vaccine. 2006;24(20):4321–7. doi:10.1016/j.vaccine.2006.03.003. PMID 16581162.
- Gerber JS, Offit PA. Vaccines and autism: a tale of shifting hypotheses. Clin Infect Dis. 2009;48(4):456–61. doi:10.1086/596476. PMID 19128068. PMC 2908388. Lay summary: IDSA, 2009-01-30.
- Willingham, Emily (29 March 2013). "Vaccines Not Linked To Autism. Again.". Forbes. Retrieved 4 April 2013.
- DeStefano, Frank; Price, Cristofer; Weintraub, Eric (1 April 2013). "Increasing Exposure to Antibody-Stimulating Proteins and Polysaccharides in Vaccines Is Not Associated with Risk of Autism". Journal of Pediatrics. doi:10.1016/j.jpeds.2013.02.001. Retrieved 4 April 2013.
- Paul R. Parents ask: am I risking autism if I vaccinate my children? J Autism Dev Disord. 2009;39(6):962–3. doi:10.1007/s10803-009-0739-y. PMID 19363650.
- The Feds say it ain't so.
- Eaton L. Measles cases in England and Wales rise sharply in 2008. BMJ. 2009;338:b533. doi:10.1136/bmj.b533. PMID 19208716.
- Choi YH, Gay N, Fraser G, Ramsay M. The potential for measles transmission in England. BMC Public Health. 2008;8:338. doi:10.1186/1471-2458-8-338. PMID 18822142.
- American Medical Association. AMA Welcomes New IOM Report Rejecting Link Between Vaccines and Autism; 2004-05-18 [cited 2007-07-23].
- American Academy of Pediatrics. What Parents Should Know About Thimerosal; 2004-05-18 [cited 2007-07-23].
- Kurt TL. ACMT position statement: the Iom report on thimerosal and autism [PDF]. J Med Toxicol. 2006;2(4):170–1. doi:10.1007/BF03161188. PMID 18072140.
- Infectious Diseases and Immunization Committee, Canadian Paediatric Society. Autistic spectrum disorder: No causal relationship with vaccines. Paediatr Child Health. 2007 [cited 2008-10-17];12(5):393–5. Also published (2007) in Can J Infect Dis Med Microbiol 18 (3): 177–9. PMID 18923720.
- Institute of Medicine, National Academy of Sciences. Immunization safety review: vaccines and autism; 2004 [cited 2007-06-13].
- "Thimerosal in vaccines". Center for Biologics Evaluation and Research, U.S. Food and Drug Administration. 2007-09-06. Retrieved 2007-10-01.
- Centers for Disease Control and Prevention. Measles, mumps, and rubella (MMR) vaccine; 2008-12-23 [cited 2009-02-14].
- World Health Organization (2006). "Thiomersal and vaccines: questions and answers". Retrieved 2009-05-19.
- National Advisory Committee on Immunization. Thimerosal: updated statement. An Advisory Committee Statement. Can Commun Dis Rep. 2007;33(ACS-6):1–13. PMID 17663033.
- European Medicines Agency. EMEA Public Statement on Thiomersal in Vaccines for Human Use; 2004-03-24 [cited 2007-07-22].
- Retraction—Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 2010-02-06;375(9713):445. doi:10.1016/S0140-6736(10)60175-4. PMID 20137807. Lay summary: BBC News, 2010-02-02.
- Wakefield A, Murch S, Anthony A et al.. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet. 1998;351(9103):637–41. doi:10.1016/S0140-6736(97)11096-0. PMID 9500320. (Retracted, see doi:10.1016/S0140-6736(10)60175-7)
- NHS. MMR the facts [cited 2007-07-29].
- Murch SH, Anthony A, Casson DH et al. Retraction of an interpretation. Lancet. 2004;363(9411):750. doi:10.1016/S0140-6736(04)15715-2. PMID 15016483.
- Deer B. The MMR-autism crisis - our story so far; 2008-11-02 [cited 2008-12-06].
- National Health Service. MMR the facts [cited 2007-06-13].
- MMR scare doctor 'paid children'. BBC News. 2007-07-16 [cited 2007-07-29].
- Deer B. MMR doctor Andrew Wakefield fixed data on autism. Sunday Times (London). 2009-02-08 [cited 2009-02-09].
- Arthur Allen. A special court rejects autism-vaccine theories..
- Godlee F, Smith J, Marcovitch H. Wakefield's article linking MMR vaccine and autism was fraudulent. BMJ. 2011;342:c7452. doi:10.1136/bmj.c7452. PMID 21209060.
- Deer B. How the case against the MMR vaccine was fixed. BMJ. 2011;342:c5347. doi:10.1136/bmj.c5347. PMID 21209059.
- Study linking vaccine to autism was fraud. 2011-01-05 [cited 2011-01-06]. Associated Press. NPR.
- Retracted autism study an 'elaborate fraud,' British journal finds. (Atlanta) 2011-01-06 [cited 2011-01-06].
- Ashwood P, Van de Water J. Is autism an autoimmune disease? Autoimmun Rev. 2004;3(7–8):557–62. doi:10.1016/j.autrev.2004.07.036. PMID 15546805.
- Ashwood P, Wills S, Van de Water J. The immune response in autism: a new frontier for autism research. J Leukoc Biol. 2006;80(1):1–15. doi:10.1189/jlb.1205707. PMID 16698940.
- Stigler KA, Sweeten TL, Posey DJ, McDougle CJ. Autism and immune factors: a comprehensive review. Res Autism Spectr Disord. 2009;3(4):840–60. doi:10.1016/j.rasd.2009.01.007.
- Wills S, Cabanlit M, Bennett J, Ashwood P, Amaral D, Van de Water J. Autoantibodies in autism spectrum disorders (ASD). Ann N Y Acad Sci. 2007;1107:79–91. doi:10.1196/annals.1381.009. PMID 17804535.
- Schmitz C, Rezaie P. The neuropathology of autism: where do we stand? Neuropathol Appl Neurobiol. 2008;34(1):4–11. doi:10.1111/j.1365-2990.2007.00872.x. PMID 17971078.
- Fox E, Amaral D, Van de Water J (October 2012). "Maternal and fetal antibrain antibodies in development and disease". Dev Neurobiol 72 (10): 1327–34. doi:10.1002/dneu.22052. PMID 22911883.
- Libbey JE, Sweeten TL, McMahon WM, Fujinami RS. Autistic disorder and viral infections. J Neurovirol. 2005;11(1):1–10. doi:10.1080/13550280590900553. PMID 15804954.
- Becker KG. Autism, asthma, inflammation, and the hygiene hypothesis. Med Hypotheses. 2007;69(4):731–40. doi:10.1016/j.mehy.2007.02.019. PMID 17412520. PMC 2048743.
- Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008;11(6):851–76. doi:10.1017/S1461145707008401. PMID 18205981.
- Kern JK, Jones AM. Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B Crit Rev. 2006;9(6):485–99. doi:10.1080/10937400600882079. PMID 17090484.
- Schultz RT. Developmental deficits in social perception in autism: the role of the amygdala and fusiform face area. Int J Dev Neurosci. 2005;23(2–3):125–41. doi:10.1016/j.ijdevneu.2004.12.012. PMID 15749240.
- Mehler MF, Purpura DP. Autism, fever, epigenetics and the locus coeruleus. Brain Res Rev. 2009;59(2):388–92. doi:10.1016/j.brainresrev.2008.11.001. PMID 19059284. Lay summary: TIME, 2009-04-07.
- Kočovská E, Fernell E, Billstedt E, Minnis H, Gillberg C (2012). "Vitamin D and autism: clinical review". Res Dev Disabil 33 (5): 1541–50. doi:10.1016/j.ridd.2012.02.015. PMID 22522213.
- Zafeiriou DI, Ververi A, Vargiami E. Childhood autism and associated comorbidities. Brain Dev. 2007;29(5):257–72. doi:10.1016/j.braindev.2006.09.003. PMID 17084999.
- Johnson TW. Dietary considerations in autism: identifying a reasonable approach. Top Clin Nutr. 2006;21(3):212–25.
- MacDonald TT, Domizio P. Autistic enterocolitis; is it a histopathological entity? Histopathology. 2007;50(3):371–9. doi:10.1111/j.1365-2559.2007.02606.x. PMID 17257133.
- Cass H, Gringras P, March J et al. Absence of urinary opioid peptides in children with autism. Arch Dis Child. 2008;93(9):745–50. doi:10.1136/adc.2006.114389. PMID 18337276. Lay summary: BBC News, 2008-03-17.
- Horvath K, Stefanatos G, Sokolski KN, Wachtel R, Nabors L, Tildon JT. Improved social and language skills after secretin administration in patients with autistic spectrum disorders. J Assoc Acad Minor Phys. 1998;9(1):9–15. PMID 9585670.
- Sturmey P. Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials. Res Dev Disabil. 2005;26(1):87–97. doi:10.1016/j.ridd.2004.09.002. PMID 15590241.
- Schultz ST, Klonoff-Cohen HS, Wingard DL, Akshoomoff NA, Macera CA, Ji M. Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: the results of a parent survey. Autism. 2008;12(3):293–307. doi:10.1177/1362361307089518. PMID 18445737.
- Good P. Did acetaminophen provoke the autism epidemic? Altern Med Rev. 2009;14(4):364–72. PMID 20030462.
- Bettelheim B. The Empty Fortress: Infantile Autism and the Birth of the Self. Free Press; 1967. ISBN 0-02-903140-0 [Amazon-US | Amazon-UK].
- Kanner L. Autistic disturbances of affective contact. Nerv Child. 1943;2:217–50. Reprinted in Acta Paedopsychiatr. 1968;35(4):100–36. PMID 4880460.
- Kanner L. Problems of nosology and psychodynamics in early childhood autism. Am J Orthopsychiatry. 1949;19(3):416–26. doi:10.1111/j.1939-0025.1949.tb05441.x. PMID 18146742.
- Gardner M. The brutality of Dr. Bettelheim. Skeptical Inquirer. 2000;24(6):12–4.
- Rutter ML, Kreppner JM, O'Connor TG, English and Romanian Adoptees (ERA) study team. Specificity and heterogeneity in children's responses to profound institutional privation. Br J Psychiatry. 2001;179(2):97–103. doi:10.1192/bjp.179.2.97. PMID 11483469.
- Hoksbergen R, ter Laak J, Rijk K, van Dijkum C, Stoutjesdijk F. Post-Institutional Autistic Syndrome in Romanian adoptees. J Autism Dev Disord. 2005;35(5):615–23. doi:10.1007/s10803-005-0005-x. PMID 16167089.
- Gomberoff M, De Gomberoff LP. Autistic devices in small children in mourning. Int J Psychoanal. 2000;81(5):907–20. doi:10.1516/0020757001600282. PMID 11109576.
- Timimi S, Taylor E. ADHD is best understood as a cultural construct. Br J Psychiatry. 2004;184:8–9. doi:10.1192/bjp.184.1.8. PMID 14702221.
- Timimi S. Diagnosis of autism: current epidemic has social context. BMJ. 2004;328(7433):226. doi:10.1136/bmj.328.7433.226-a. PMID 14739199. PMC 318517.
- Hacking I. The Social Construction of What? Harvard University Press; 1999. ISBN 0-674-00412-4 [Amazon-US | Amazon-UK]. p. 114–23.
- Nadesan MH. Constructing Autism: Unravelling the 'Truth' and Understanding the Social. Routledge; 2005. ISBN 0-415-32181-6 [Amazon-US | Amazon-UK]. The dialectics of autism: theorizing autism, performing autism, remediating autism, and resisting autism. p. 179–213.
- The Oxford Handbook of Evolutionary Psychology, Edited by Robin Dunbar and Louise Barret, Oxford University Press, 2007, Chapter 16 The evolution of empathizing and systemizing: assortative mating of two strong systemizers and the cause of autism, Simon Baron-Cohen.
- Schlomer, G. L.; Del Giudice, M.; Ellis, B. J. (2011). "Parent–offspring conflict theory: An evolutionary framework for understanding conflict within human families". Psychological Review 118 (3): 496–521. doi:10.1037/a0024043. PMID 21604906.
- Badcock, C.; Crespi, B. (2008). "Battle of the sexes may set the brain". Nature 454 (7208): 1054–1055. doi:10.1038/4541054a. PMID 18756240.